WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Laura Lee SandlerChief Operating Officer2026-05-015,000$7.80
$39.00kBuy
Laura Lee SandlerChief Operating Officer2026-05-01100$68.48
$6.85kSell
Laura Lee SandlerChief Operating Officer2026-05-01200$67.16
$13.43kSell
Laura Lee SandlerChief Operating Officer2026-05-01400$66.06
$26.42kSell
Laura Lee SandlerChief Operating Officer2026-05-01300$65.10
$19.53kSell
Laura Lee SandlerChief Operating Officer2026-05-011,800$64.15
$115.47kSell
Laura Lee SandlerChief Operating Officer2026-05-012,200$62.58
$137.68kSell
Joana GoncalvesChief Medical Officer2026-04-153,500$7.80
$27.30kBuy
Joana GoncalvesChief Medical Officer2026-04-15500$67.38
$33.69kSell
Joana GoncalvesChief Medical Officer2026-04-152,273$66.56
$151.30kSell

1 of 5

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter W. Sonsini20.63%10,221,465$704.77MInsider
Harry R. Weller20.63%10,221,465$704.77MInsider
Ravi Viswanathan20.63%10,221,465$704.77MInsider
Scott D. Sandell20.63%10,221,465$704.77MInsider
Jon Sakoda20.63%10,221,465$704.77MInsider
David M. Mott20.63%10,221,465$704.77MInsider
Joshua Makower20.63%10,221,465$704.77MInsider
Krishna Kittu Kolluri20.63%10,221,465$704.77MInsider
Anthony A. Florence Jr.20.63%10,221,465$704.77MInsider
Forest Baskett20.63%10,221,465$704.77MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA25.56%74.44%Net BuyingNet Selling
ERAS70.55%27.68%Net BuyingNet Buying
TNGX67.43%32.57%Net SellingNet Selling
NAMS74.47%25.53%Net SellingNet Selling
BEAM86.28%13.72%Net SellingNet Selling
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 106.68% institutional shareholders, 310.65% Oruka Therapeutics insiders, and 0.00% retail investors. Peter W. Sonsini is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 20.63% of the company. Peter W. Sonsini's Oruka Therapeutics shares are currently valued at $713.36M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.